Literature DB >> 22537684

The use of hormonal contraceptive agents and mood disorders in women.

Gjertrud Svendal1, Michael Berk, Julie A Pasco, Felice N Jacka, Anders Lund, Lana J Williams.   

Abstract

BACKGROUND: Mood disorders are a major cause of disability in developed countries, and contraceptive agents among the most widely used medications. The relationship between contraceptive agents and mood is unclear. The aim of this study was therefore to investigate the association between current contraception use and mood disorders in a random population-based sample of women.
METHODS: This study examined epidemiological data obtained from 498 women aged 20-50year participating in the Geelong Osteoporosis Study (GOS). Mood disorders were diagnosed using a clinical interview (SCID-I/NP) and information on medication use and other lifestyle factors were documented.
RESULTS: After adjusting for age and socioeconomic status (SES), women taking progestin-only contraceptive agents had an increased likelihood of a current mood disorder (OR 3.0 95%CI: 1.1-7.8, p=0.03). In contrast, women taking combined contraceptive agents had a decreased likelihood of a current mood disorder, adjusting this for age and SES (OR 0.3 95%CI: 0.1, 0.9 p=0.03). These findings were not explained by weight, physical activity level, past depression, number of medical conditions or cigarette smoking. LIMITATIONS: This study is cross-sectional, which precludes any determination regarding the direction of the relationships.
CONCLUSIONS: These data suggest a protective effect of the combined contraceptive pill, and a deleterious effect of progestin only agents in regards to mood disorders.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22537684     DOI: 10.1016/j.jad.2012.03.030

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

1.  Psychological, social, and spiritual effects of contraceptive steroid hormones.

Authors:  Hanna Klaus; Manuel E Cortés
Journal:  Linacre Q       Date:  2015-08

2.  Reproductive endocrinology: The emotional cost of contraception.

Authors:  Rachel A Ross; Ursula B Kaiser
Journal:  Nat Rev Endocrinol       Date:  2016-12-08       Impact factor: 43.330

3.  Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.

Authors:  Jessica L Castilho; Cathy A Jenkins; Bryan E Shepherd; Sally S Bebawy; Megan Turner; Timothy R Sterling; Vlada V Melekhin
Journal:  J Womens Health (Larchmt)       Date:  2015-03-09       Impact factor: 2.681

Review 4.  Hormonal Treatments for Major Depressive Disorder: State of the Art.

Authors:  Jennifer B Dwyer; Awais Aftab; Rajiv Radhakrishnan; Alik Widge; Carolyn I Rodriguez; Linda L Carpenter; Charles B Nemeroff; William M McDonald; Ned H Kalin
Journal:  Am J Psychiatry       Date:  2020-05-27       Impact factor: 18.112

5.  Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged.

Authors:  William V Williams; Joel Brind; Laura Haynes; Michael D Manhart; Hanna Klaus; Angela Lanfranchi; Gerard Migeon; Mike Gaskins; Elvis I Seman; Lester Ruppersberger; Kathleen M Raviele
Journal:  Linacre Q       Date:  2021-01-27

6.  [Physician's obligations to inform about complications based on a recent warning from drug authorities].

Authors:  G Duttge; T Meyer
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-02-07       Impact factor: 0.840

7.  Development and remission of depressive symptoms and treatment with hormonal contraceptives.

Authors:  Mette Nygaard Andersen; Per Bech; Claudio Csillag
Journal:  Oxf Med Case Reports       Date:  2014-06-27

8.  Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: A pharmacoepidemiological study on 800 000 Swedish women.

Authors:  Sofia Zettermark; Raquel Perez Vicente; Juan Merlo
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

Review 9.  Mechanisms of estradiol in fear circuitry: implications for sex differences in psychopathology.

Authors:  K K Cover; L Y Maeng; K Lebrón-Milad; M R Milad
Journal:  Transl Psychiatry       Date:  2014-08-05       Impact factor: 6.222

10.  Do Progestin-Only Contraceptives Contribute to the Risk of Developing Depression as Implied by Beta-Arrestin 1 Levels in Leukocytes? A Pilot Study.

Authors:  Keisha Smith; Sanket Nayyar; Tanu Rana; Anthony E Archibong; Kimberly R Looney; Tultul Nayyar
Journal:  Int J Environ Res Public Health       Date:  2018-09-09       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.